SZSE:300452 (China)
Â
Class A
Â¥
11.57
(-0.86%)
Jan 15
Business Description
Anhui Sunhere Pharmaceutical Excipients Co Ltd
ISIN : CNE100001ZH5
Share Class Description:
SZSE:300452: Class ACompare
Compare
Traded in other countries / regions
300452.China IPO Date
2015-05-15Description
Anhui Sunhere Pharmaceutical Excipients Co Ltd is engaged in the research, development, production, and sales of pharmaceutical excipients. It is a pharmaceutical excipient manufacturer and is the oral product's producer in China. The company's products are cover fillers, adhesives, disintegrants, lubricants, coating materials and other common oral solid preparations.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.99 | |||||
| Equity-to-Asset | 0.58 | |||||
| Debt-to-Equity | 0.35 | |||||
| Debt-to-EBITDA | 1.62 | |||||
| Interest Coverage | 14.88 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.72 | |||||
| Beneish M-Score | -2.24 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.7 | |||||
| 3-Year EBITDA Growth Rate | 16.1 | |||||
| 3-Year EPS without NRI Growth Rate | 17 | |||||
| 3-Year FCF Growth Rate | 4.7 | |||||
| 3-Year Book Growth Rate | 14 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.65 | |||||
| 9-Day RSI | 41.73 | |||||
| 14-Day RSI | 40.68 | |||||
| 6-1 Month Momentum % | 18.25 | |||||
| 12-1 Month Momentum % | -5.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.08 | |||||
| Quick Ratio | 3.67 | |||||
| Cash Ratio | 2.64 | |||||
| Days Inventory | 53.38 | |||||
| Days Sales Outstanding | 50.53 | |||||
| Days Payable | 123.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.14 | |||||
| Dividend Payout Ratio | 0.36 | |||||
| 3-Year Dividend Growth Rate | 19.1 | |||||
| Forward Dividend Yield % | 2.14 | |||||
| 5-Year Yield-on-Cost % | 7.87 | |||||
| Shareholder Yield % | -3.05 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 32.21 | |||||
| Operating Margin % | 20.95 | |||||
| Net Margin % | 19.03 | |||||
| FCF Margin % | 9.75 | |||||
| ROE % | 18.3 | |||||
| ROA % | 10.47 | |||||
| ROIC % | 23.13 | |||||
| 3-Year ROIIC % | 35.15 | |||||
| ROC (Joel Greenblatt) % | 39 | |||||
| ROCE % | 15.25 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 17.53 | |||||
| Forward PE Ratio | 11.81 | |||||
| PE Ratio without NRI | 16.87 | |||||
| Shiller PE Ratio | 28.22 | |||||
| Price-to-Owner-Earnings | 21.07 | |||||
| PEG Ratio | 1.08 | |||||
| PS Ratio | 3.35 | |||||
| PB Ratio | 2.98 | |||||
| Price-to-Tangible-Book | 3.32 | |||||
| Price-to-Free-Cash-Flow | 37.83 | |||||
| Price-to-Operating-Cash-Flow | 27.49 | |||||
| EV-to-EBIT | 12.75 | |||||
| EV-to-EBITDA | 12.75 | |||||
| EV-to-Revenue | 2.95 | |||||
| EV-to-FCF | 29.26 | |||||
| Price-to-Projected-FCF | 1.82 | |||||
| Price-to-DCF (Earnings Based) | 0.9 | |||||
| Price-to-DCF (FCF Based) | 3.28 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.08 | |||||
| Price-to-Graham-Number | 1.58 | |||||
| Price-to-Net-Current-Asset-Value | 8.26 | |||||
| Earnings Yield (Greenblatt) % | 7.84 | |||||
| FCF Yield % | 3.03 | |||||
| Forward Rate of Return (Yacktman) % | 17.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Anhui Sunhere Pharmaceutical Excipients Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 843.258 | ||
| EPS (TTM) (Â¥) | 0.66 | ||
| Beta | 0.95 | ||
| Volatility % | 35.37 | ||
| 14-Day RSI | 40.68 | ||
| 14-Day ATR (Â¥) | 0.329487 | ||
| 20-Day SMA (Â¥) | 12.0965 | ||
| 12-1 Month Momentum % | -5.08 | ||
| 52-Week Range (Â¥) | 9.92 - 15.4 | ||
| Shares Outstanding (Mil) | 234.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Anhui Sunhere Pharmaceutical Excipients Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Anhui Sunhere Pharmaceutical Excipients Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Anhui Sunhere Pharmaceutical Excipients Co Ltd Frequently Asked Questions
What is Anhui Sunhere Pharmaceutical Excipients Co Ltd(SZSE:300452)'s stock price today?
The current price of SZSE:300452 is ¥11.57. The 52 week high of SZSE:300452 is ¥15.40 and 52 week low is ¥9.92.
When is next earnings date of Anhui Sunhere Pharmaceutical Excipients Co Ltd(SZSE:300452)?
The next earnings date of Anhui Sunhere Pharmaceutical Excipients Co Ltd(SZSE:300452) is .
Does Anhui Sunhere Pharmaceutical Excipients Co Ltd(SZSE:300452) pay dividends? If so, how much?
The Dividend Yield %  of Anhui Sunhere Pharmaceutical Excipients Co Ltd(SZSE:300452) is 2.14% (As of Today), Highest Dividend Payout Ratio of Anhui Sunhere Pharmaceutical Excipients Co Ltd(SZSE:300452) was 0.59. The lowest was 0.21. And the median was 0.39. The  Forward Dividend Yield % of Anhui Sunhere Pharmaceutical Excipients Co Ltd(SZSE:300452) is 2.14%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers